We have examined the pattern of striatal messenger RNA expression of over 8000 genes in a rat model of levodopa (L-DOPA)-induced dyskinesia and Parkinson disease (PD). 6-Hydroxydopamine (6-OHDA)-lesioned rats were treated with L-DOPA or physiological saline for 22 days and repeatedly tested for antiakinetic response to L-DOPA and the development of abnormal involuntary movements (AIMs). In a comparison of rats that developed a dyskinetic motor response to rats that did not, we found striking differences in gene expression patterns. In rats that developed dyskinesia, GABA neurons had an increased transcriptional activity, and genes involved in Ca2+ homeostasis, in Ca2+-dependent signaling, and in structural and synaptic plasticity were upreg...
The crucial role of dopamine (DA) in movement control is illustrated by the spectrum of motor disord...
<div><p>This study addresses the molecular mechanisms underlying the action of subthalamic nucleus h...
International audienceThis study addresses the molecular mechanisms underlying the action of subthal...
We have examined the pattern of striatal messenger RNA expression of over 8000 genes in a rat model ...
L-DOPA is the gold standard treatment for Parkinson’s disease. However, with prolonged use the major...
L-DOPA is the primary pharmacological treatment for relief of the motor symptoms of Parkinson’s dise...
L-DOPA-induced dyskinesia (abnormal involuntary movements) is one of the most debilitating complicat...
International audienceWe compared for the first time the effects of de novo versus long-term l-Dopa ...
Parkinson's disease (PD) is a neurodegenerative disorder where the midbrain dopaminergic neurons are...
This study explores the role of transcriptional regulation important in the development of L-DOPA-in...
Whether the treatment of Parkinson's disease has to be initiated with levodopa or a D2 agonist like ...
The development of L-DOPA-induced dyskinesia (LID) is attributed to plastic responses triggered by d...
International audienceLong-term l-3,4-dihydroxyphenylalanine (l-DOPA) treatment in Parkinson's disea...
Current knowledge of the molecular changes induced by dopamine denervation and subsequent treatment ...
Numerous genes, and alterations in their expression, have been identified as risk factors for develo...
The crucial role of dopamine (DA) in movement control is illustrated by the spectrum of motor disord...
<div><p>This study addresses the molecular mechanisms underlying the action of subthalamic nucleus h...
International audienceThis study addresses the molecular mechanisms underlying the action of subthal...
We have examined the pattern of striatal messenger RNA expression of over 8000 genes in a rat model ...
L-DOPA is the gold standard treatment for Parkinson’s disease. However, with prolonged use the major...
L-DOPA is the primary pharmacological treatment for relief of the motor symptoms of Parkinson’s dise...
L-DOPA-induced dyskinesia (abnormal involuntary movements) is one of the most debilitating complicat...
International audienceWe compared for the first time the effects of de novo versus long-term l-Dopa ...
Parkinson's disease (PD) is a neurodegenerative disorder where the midbrain dopaminergic neurons are...
This study explores the role of transcriptional regulation important in the development of L-DOPA-in...
Whether the treatment of Parkinson's disease has to be initiated with levodopa or a D2 agonist like ...
The development of L-DOPA-induced dyskinesia (LID) is attributed to plastic responses triggered by d...
International audienceLong-term l-3,4-dihydroxyphenylalanine (l-DOPA) treatment in Parkinson's disea...
Current knowledge of the molecular changes induced by dopamine denervation and subsequent treatment ...
Numerous genes, and alterations in their expression, have been identified as risk factors for develo...
The crucial role of dopamine (DA) in movement control is illustrated by the spectrum of motor disord...
<div><p>This study addresses the molecular mechanisms underlying the action of subthalamic nucleus h...
International audienceThis study addresses the molecular mechanisms underlying the action of subthal...